Why GLP-1 Drug Usage Has Increased So Rapidly Three primary drivers explain the explosive growth in GLP-1 medication adoption over the past 24-36 months
Estimated Glomerular Filtration Rate (eGFR) and Disease Stage 48 In stage 1 , the eGFR is within normal limits (90 mL/min/1.73 m 2 ) and the kidneys are still working adequately, but the presence of protein in the urine is indicative of mild kidney damage
In other words, if you have not experienced significant GI side effects by week 20, you are unlikely to develop them going forward on a stable dose
High dosages can get you mild side effects like diarrhea, nausea, dizziness, headaches, or a very warm burning feeling in the injection area
Message your provider Have a question between consults
Retrieved March 10, 2026, from 6 Williams, E., Rudowitz, R., & Bell, C